Literature DB >> 32084302

Glucose transporter 1 in rheumatoid arthritis and autoimmunity.

Ekaterina Zezina1, Oezen Sercan-Alp1, Matthias Herrmann1, Nadine Biesemann1.   

Abstract

Knowledge about metabolism of immune cells increased almost exponentially during the last two decades and thereby created the new area immunometabolism. Increased glucose uptake and glycolysis were identified as one of the major drivers in immune cells for rapid adaptation to changes in the microenvironment or external stimuli. These metabolic switches are crucial to generate macromolecules for immune cell proliferation and activation. Glucose transporter 1 (GLUT1), a ubiquitously expressed glucose transporter, is strongly upregulated after innate and adaptive immune cell activation. Deletion or inhibition of GLUT1 blocked T cell proliferation and effector function, antibody production from B cells and reduced inflammatory responses in macrophages. Increased glucose uptake and GLUT1 expression are not only observed in proinflammatory conditions, but also in murine models of autoimmunity as well as in human patients. Rheumatoid arthritis (RA), the most common autoimmune disease, is characterized by infiltration of immune cells, hyperproliferation of fibroblast-like synoviocytes, and destruction of cartilage and bone. These processes create a hypoxic microenvironment in the synovium. Moreover, synovial samples including fibroblast-like synoviocytes from RA patients showed increased lactate level and upregulate GLUT1. Similar upregulation of GLUT1 is observed in systemic lupus erythematosus and psoriasis patients as well as in murine autoimmune models. Inhibition of GLUT1 using either T cell specific knockouts or small molecule GLUT1/glycolysis inhibitors improved phenotypes of different murine autoimmune disease models like arthritis, lupus, and psoriasis. Thereby the therapeutic potential of immunometabolism and especially interference with glycolysis was proven. This article is categorized under: Biological Mechanisms > Metabolism Translational, Genomic, and Systems Medicine > Translational Medicine Physiology > Mammalian Physiology in Health and Disease.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  GLUT1; autoimmunity; glycolysis; immunometabolism; rheumatoid arthritis

Year:  2020        PMID: 32084302     DOI: 10.1002/wsbm.1483

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Syst Biol Med        ISSN: 1939-005X


  5 in total

Review 1.  Metabolic Reprogramming of Innate Immune Cells as a Possible Source of New Therapeutic Approaches in Autoimmunity.

Authors:  Leila Mohammadnezhad; Mojtaba Shekarkar Azgomi; Marco Pio La Manna; Guido Sireci; Chiara Rizzo; Giusto Davide Badami; Bartolo Tamburini; Francesco Dieli; Giuliana Guggino; Nadia Caccamo
Journal:  Cells       Date:  2022-05-17       Impact factor: 7.666

Review 2.  Glycolysis Rate-Limiting Enzymes: Novel Potential Regulators of Rheumatoid Arthritis Pathogenesis.

Authors:  Jianlin Zuo; Jinshuo Tang; Meng Lu; Zhongsheng Zhou; Yang Li; Hao Tian; Enbo Liu; Baoying Gao; Te Liu; Pu Shao
Journal:  Front Immunol       Date:  2021-11-24       Impact factor: 7.561

3.  Multi-omics profiling of collagen-induced arthritis mouse model reveals early metabolic dysregulation via SIRT1 axis.

Authors:  Lingzi Li; Janina Freitag; Christian Asbrand; Bogdan Munteanu; Bei-Tzu Wang; Ekaterina Zezina; Michel Didier; Gilbert Thill; Corinne Rocher; Matthias Herrmann; Nadine Biesemann
Journal:  Sci Rep       Date:  2022-07-12       Impact factor: 4.996

Review 4.  Glucose metabolism and glycosylation link the gut microbiota to autoimmune diseases.

Authors:  Lu Wang; Haojie Xu; Huaxia Yang; Jiaxin Zhou; Lidan Zhao; Fengchun Zhang
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

5.  TNF induces glycolytic shift in fibroblast like synoviocytes via GLUT1 and HIF1A.

Authors:  Kathrin Koedderitzsch; Ekaterina Zezina; Lingzi Li; Matthias Herrmann; Nadine Biesemann
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.